Timothy A Carey1, William B Stiles2. 1. Centre for Remote Health, A Joint Centre of Flinders University and Charles Darwin University, Alice Springs, Australia. 2. Department of Psychology, Miami University, Oxford, OH, USA.
Abstract
UNLABELLED: Randomized controlled trials (RCTs) are currently the dominant methodology for evaluating psychological treatments. They are widely regarded as the gold standard, and in the current climate, it is unlikely that any particular psychotherapy would be considered evidence-based unless it had been subjected to at least one, and usually more, RCTs. Despite the esteem within which they are held, RCTs have serious shortcomings. They are the methodology of choice for answering some questions but are not well suited for answering others. In particular, they seem poorly suited for answering questions related to why therapies work in some situations and not in others and how therapies work in general. Ironically, the questions that RCTs cannot answer are the questions that are of most interest to clinicians and of most benefit to patients. In this paper, we review some of the shortcomings of RCTs and suggest a number of other approaches. With a more nuanced understanding of the strengths and weaknesses of RCTs and a greater awareness of other research strategies, we might begin to develop a more realistic and precise understanding of which treatment options would be most effective for particular clients with different problems and in different circumstances.
UNLABELLED: Randomized controlled trials (RCTs) are currently the dominant methodology for evaluating psychological treatments. They are widely regarded as the gold standard, and in the current climate, it is unlikely that any particular psychotherapy would be considered evidence-based unless it had been subjected to at least one, and usually more, RCTs. Despite the esteem within which they are held, RCTs have serious shortcomings. They are the methodology of choice for answering some questions but are not well suited for answering others. In particular, they seem poorly suited for answering questions related to why therapies work in some situations and not in others and how therapies work in general. Ironically, the questions that RCTs cannot answer are the questions that are of most interest to clinicians and of most benefit to patients. In this paper, we review some of the shortcomings of RCTs and suggest a number of other approaches. With a more nuanced understanding of the strengths and weaknesses of RCTs and a greater awareness of other research strategies, we might begin to develop a more realistic and precise understanding of which treatment options would be most effective for particular clients with different problems and in different circumstances.
Authors: Rowan G M Smeets; Dorijn F L Hertroijs; Ferdinand C Mukumbang; Mariëlle E A L Kroese; Dirk Ruwaard; Arianne M J Elissen Journal: Milbank Q Date: 2021-11-23 Impact factor: 4.911
Authors: Gerardo Calderon; Daniel Gonzalez-Izundegui; Kuangda L Shan; Oscar A Garcia-Valencia; Lizeth Cifuentes; Alejandro Campos; Maria L Collazo-Clavell; Meera Shah; Daniel L Hurley; Haitham S Abu Lebdeh; Mayank Sharma; Kristine Schmitz; Matthew M Clark; Karen Grothe; Manpreet S Mundi; Michael Camilleri; Barham K Abu Dayyeh; Maria D Hurtado Andrade; Mohamad A Mokadem; Andres Acosta Journal: Int J Obes (Lond) Date: 2021-11-22 Impact factor: 5.095
Authors: Joanna E Steinglass; Evelyn Attia; Deborah R Glasofer; Yuanjia Wang; Julia Ruggiero; B Timothy Walsh; J Graham Thomas Journal: Int J Eat Disord Date: 2022-04-30 Impact factor: 5.791
Authors: Claire Hill; Cathy Creswell; Sarah Vigerland; Maaike H Nauta; Sonja March; Caroline Donovan; Lidewij Wolters; Susan H Spence; Jennifer L Martin; Lori Wozney; Lauren McLellan; Leonie Kreuze; Karen Gould; Maral Jolstedt; Martina Nord; Jennifer L Hudson; Elisabeth Utens; Jeroen Ruwaard; Casper Albers; Muniya Khanna; Anne Marie Albano; Eva Serlachius; Stefan Hrastinski; Philip C Kendall Journal: Internet Interv Date: 2018-02-19
Authors: Aleena M Wojcieszek; Alexander Ep Heazell; Philippa Middleton; David Ellwood; Robert M Silver; Vicki Flenady Journal: BMJ Open Date: 2019-06-22 Impact factor: 2.692